Jerman Michael Allen — SEC Form 4 filings
SEC reporting owner CIK 1979732. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-27.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-27 to 2026-07-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | Director | 5 | — | — | 6 |
| Inhibitor Therapeutics, Inc. (INTI) | Director | 3 | — | — | 3 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | Director | 1 | — | — | 1 |
| Telomir Pharmaceuticals, Inc. (TELO) | Director | 1 | — | — | 1 |
Form 4 filings — Jerman Michael Allen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 8,138 @ $1.92 | EDGAR |
| 2026-06-24 | 4 | Inhibitor Therapeutics, Inc. (INTI) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-05-01 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 6,032 @ $2.59 | EDGAR |
| 2026-01-15 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 5,406 @ $2.89 | EDGAR |
| 2025-11-26 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 4,183 @ $3.16 | EDGAR |
| 2025-07-17 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 3,200 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Inhibitor Therapeutics, Inc. (INTI) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-08-29 | 4 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Inhibitor Therapeutics, Inc. (INTI) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-03-27 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1979732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →